Birkbeck, University of London Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
University of Kent Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
European Molecular Biology Laboratory (Heidelberg) Featured PhD Programmes
"formulation"×
10 miles

Cancer / Oncology (formulation) PhD Projects, Programs & Scholarships

We have 4 Cancer / Oncology (formulation) PhD Projects, Programs & Scholarships

  • "formulation" ×
  • Cancer / Oncology×
  • clear all
Order by 
Showing 1 to 4 of 4
  Formulation and evaluation of umbilical cord-derived mesenchymal stem cells exosomes and antioxidants, incorporated in nanoliposomes using microfluidics, for the treatment of solid tumours
  Research Group: Chemistry and Biosciences
  Dr M Najafzadeh, Prof D Anderson, Dr M Isreb
Applications accepted all year round

Funding Type

PhD Type

This project uses the Cord blood Stem Cells from healthy control and the white blood cells of blood cancer patients to investigate the efficacy and genotoxicity of different compounds in them by using various genetic endpoints.
  Improving the success of antibody based drugs by characterising the patients’ immune system
  Dr A Watts
Application Deadline: 17 November 2019

Funding Type

PhD Type

The University of Bath, in conjunction with Qualasept Ltd, is inviting applications for a fully-funded PhD studentship. SUPERVISORY TEAM.
  Bioinspired worm-like nanoparticles for the delivery of anti-cancer stem cell agents
  Dr K Suntharalingam, Dr R Britton
Application Deadline: 21 November 2019

Funding Type

PhD Type

Cancer relapse and metastasis, the leading cause of cancer-associated deaths, is strongly linked to the existence of cancer stem cells (CSCs), a small sub-population of cancer cells defined by their ability to self-renew, differentiate, and form secondary tumours.
  Designing novel composite polysaccharide nanoparticles for combined diagnosis and treatment of cancers
  Dr E Barbu, Dr A Lalatsa
Applications accepted all year round

Funding Type

PhD Type

Cancer continues to impose a vast burden with regard to financial costs as well as human suffering but the progress in its treatment is hindered by the limited selectivity and significant side-effects that the current chemotherapy demonstrates, representing a major challenge for modern drug delivery.
Show 10 15 30 per page
  • 1


FindAPhD. Copyright 2005-2019
All rights reserved.